Background and objectives: To evaluate the extent of intrathecal inflammation in patients with primary progressive MS (PPMS) at the time of diagnosis and to define markers and a specific inflammatory profile capable of distinguishing progressive from relapsing-remitting multiple sclerosis (RRMS). Methods: Levels of 34 pro- and anti-inflammatory cytokines and chemokines in the CSF were evaluated at the diagnosis in 16 patients with PPMS and 80 with RRMS. All patients underwent clinical evaluation, including Expanded Disability Status Scale assessment and a 3T brain MRI to detect white matter and cortical lesion number and volume and global and regional cortical thickness. Results: Higher levels of CXCL12 (odds ratio [OR] = 3.97, 95% CI [1....
Several biomarkers from multiple sclerosis (MS) patients' biological fluids have been considered to ...
OBJECTIVE: Intrathecal inflammation, compartmentalized in cerebrospinal fluid (CSF) and in meningeal...
Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical an...
BACKGROUND: Clinical and imaging follow-up coupled with cerebrospinal fluid (CSF) and possibly serum...
Background: Disease activity in the first years after a diagnosis of relapsing-remitting multiple sc...
Background: Grey matter (GM) damage provides the best correlate of the variable accumulation of phy...
Multiple Sclerosis (MS) is considered an autoimmune disease of the central nervous system (CNS). It ...
OBJECTIVE: Grey matter (GM) damage and meningeal inflammation have been associated with early diseas...
BACKGROUND: Although IgG oligoclonal bands (OCBs) in the cerebrospinal fluid (CSF) are a frequent p...
Objective: To identify biomarkers associated with progressive phases of MS and with neuroprotective ...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). MS usually sta...
Meningeal inflammation, including the presence of semi-organized tertiary lymphoid tissue, has been ...
OBJECTIVE: This study aimed to identify long-term prognostic protein biomarkers associated with dise...
Objective: The aim of this study was to report the basic cerebrospinal fluid (CSF) profile in patien...
Objective: Intrathecal inflammation correlates with the grey matter damage since the early stages of...
Several biomarkers from multiple sclerosis (MS) patients' biological fluids have been considered to ...
OBJECTIVE: Intrathecal inflammation, compartmentalized in cerebrospinal fluid (CSF) and in meningeal...
Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical an...
BACKGROUND: Clinical and imaging follow-up coupled with cerebrospinal fluid (CSF) and possibly serum...
Background: Disease activity in the first years after a diagnosis of relapsing-remitting multiple sc...
Background: Grey matter (GM) damage provides the best correlate of the variable accumulation of phy...
Multiple Sclerosis (MS) is considered an autoimmune disease of the central nervous system (CNS). It ...
OBJECTIVE: Grey matter (GM) damage and meningeal inflammation have been associated with early diseas...
BACKGROUND: Although IgG oligoclonal bands (OCBs) in the cerebrospinal fluid (CSF) are a frequent p...
Objective: To identify biomarkers associated with progressive phases of MS and with neuroprotective ...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). MS usually sta...
Meningeal inflammation, including the presence of semi-organized tertiary lymphoid tissue, has been ...
OBJECTIVE: This study aimed to identify long-term prognostic protein biomarkers associated with dise...
Objective: The aim of this study was to report the basic cerebrospinal fluid (CSF) profile in patien...
Objective: Intrathecal inflammation correlates with the grey matter damage since the early stages of...
Several biomarkers from multiple sclerosis (MS) patients' biological fluids have been considered to ...
OBJECTIVE: Intrathecal inflammation, compartmentalized in cerebrospinal fluid (CSF) and in meningeal...
Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical an...